Search results for: 'diseas virtualization market size'

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

11 Jan 2021  |  North America  |  Market Research

Increasing Demand for Value-based Care and Acute Shortage of ICU Staff to Drive Growth of the US & EU-5 Virtual Critical Care Solutions Market, 2025

Future Growth Potential to Be Accelerated by Opportunities in Affordable, Easy-to-Deploy, and Scalable Solutions

Infographics

×

Coronavirus (COVID-19) has fuelled a demand for solutions that can help cater to large patient populations remotely. Further, the shortage of intensivists, as estimated by the COMPACCS trial, is expected to increase from 22% in 2020 to 35% by 2030. These, as well as changing reimbursement policies, are some of the key trends that will define the fu...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

Over the recent years, the MVNO or the Mobile Virtual Network Operator model has experienced a challenging growth prospect in the wireless communications space. This report offers a comprehensive overview of the MVNO phenomenon, and believes that such partnerships will be prevalent, and key to success in the forthcoming third-generation wireless wo...

Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...

Frost & Sullivan research found the visible market success of artificial intelligence (AI)-driven interactive virtual assistants (IVAs), such as Alexa from Amazon and the Google Assistant, has been matched by specialized IVA deployments in various vertical markets such as financial services, education, and retail. Healthcare has presented opportun...

As businesses embrace SD-WAN, they are quickly realizing that a holistic approach to enterprise WAN virtualization is critical, and several aspects of traditional WAN edge or branch infrastructure will need to change to make the WAN truly agileNFV-based virtual network services have been available in the market since 2016, with slow market adoption...

06 Oct 2021  |  North America  |  Market Research

US Chronic Disease Management Growth Opportunities

Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management

Infographics

×

Key Issues Addressed

The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches ...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...